Pharmaceutical company Bayer on Thursday said it will pay roughly $1.6 billion to settle approximately 90% of U.S. claims involving its Essure contraceptive device that injured thousands of women.
Around 39,000 women have claimed in lawsuits that the metal coil device, which is inserted into the fallopian tubes to permanently block its reproductive functions, could pierce the tubes and migrate to other parts of the body.
Bayer said it stands by Essure's safety and efficacy and that the company was settling the lawsuit in order to focus on women's health "without the distractions" of the litigation.
The company also said it would not admit to any culpability and will not apologize to the women who were injured.
"There is no admission of wrongdoing or liability by Bayer in the settlement agreements," the pharmaceutical giant said.
The birth-control device was discontinued in dozens of countries in 2017 before being taken off U.S. shelves the following year.
Bayer said the decision to remove the device from stores was due to declining sales rather than an issue of safety.